Anal Carcinoma

The POD1UM-303 Triumph: Retifanlimab, Mitomycin Toxicity, and Frontline Anal Oncology

In this episode of The Gut Onc Lab, Drs. Nicholas Hornstein, Timothy Brown, and Udhayvir Grewal dive into a disease site currently undergoing a massive therapeutic shift: anal cancer. As an inherently HPV- and HIV-associated malignancy, managing anal...
Listen now
The POD1UM-303 Triumph: Retifanlimab, Mitomycin Toxicity, and Frontline Anal Oncology